Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China; Neurofibromatosis Type 1 Center and Laboratory for Neurofibromatosis Type 1 Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China; Neurofibromatosis Type 1 Center and Laboratory for Neurofibromatosis Type 1 Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Cancer Lett. 2024 Sep 1;599:217151. doi: 10.1016/j.canlet.2024.217151. Epub 2024 Jul 31.
Plexiform neurofibromas (PNFs) are a prevalent and severe phenotype associated with NF1, characterized by a high teratogenic rate and potential for malignant transformation. The growth and recurrence of PNFs are attributed to aberrant proliferation and migration of Nf1-deficient Schwann cells. Protein tyrosine phosphatase receptor S (PTPRS) is believed to modulate cell migration and invasion by inhibiting the EMT process in NF1-derived malignant peripheral nerve sheath tumors. Nevertheless, the specific role of PTPRS in NF1-derived PNFs remains to be elucidated. The study utilized the GEO database and tissue microarray to illustrate a decrease in PTPRS expression in PNF tissues, linked to tumor recurrence. Furthermore, the down- and over-expression of PTPRS in Nf1-deficient Schwann cell lines resulted in the changes of cell migration and EMT processes. Additionally, RTK assay and WB showed that PTPRS knockdown can promote EGFR expression and phosphorylation. The restoration of EMT processes disrupted by alterations in PTPRS levels in Schwann cells can be achieved through EGFR knockdown and EGFR inhibitor. Moreover, high EGFR expression has been significantly correlated with poor prognosis. These findings underscore the potential role of PTPRS as a tumor suppressor in the recurrence of PNF via the regulation of EGFR-mediated EMT processes, suggesting potential targets for future clinical interventions.
丛状神经纤维瘤(PNFs)是一种与 NF1 相关的普遍且严重的表型,其特征是致畸率高,且有恶性转化的潜在风险。PNFs 的生长和复发归因于 Nf1 缺陷性施万细胞的异常增殖和迁移。蛋白酪氨酸磷酸酶受体 S(PTPRS)被认为通过抑制 NF1 衍生的恶性周围神经鞘瘤中的 EMT 过程来调节细胞迁移和侵袭。然而,PTPRS 在 NF1 衍生的 PNF 中的具体作用仍有待阐明。该研究利用 GEO 数据库和组织微阵列表明,PNF 组织中 PTPRS 的表达减少与肿瘤复发有关。此外,下调和过表达 Nf1 缺陷性施万细胞系中的 PTPRS 会导致细胞迁移和 EMT 过程的变化。此外,RTK 测定和 WB 表明,PTPRS 敲低可促进 EGFR 的表达和磷酸化。通过 EGFR 敲低和 EGFR 抑制剂可以破坏 PTPRS 水平变化引起的 EMT 过程的恢复。此外,高 EGFR 表达与预后不良显著相关。这些发现强调了 PTPRS 通过调节 EGFR 介导的 EMT 过程在 PNF 复发中作为肿瘤抑制因子的潜在作用,提示未来临床干预的潜在靶点。